Literature DB >> 1647521

Anthracycline antibiotic arugomycin binds in both grooves of the DNA helix simultaneously: an NMR and molecular modelling study.

M S Searle1, W Bicknell, L P Wakelin, W A Denny.   

Abstract

Perturbations to the 1H and 31P chemical shifts of DNA resonances together with twenty-four intermolecular nuclear Overhauser effects show that the anthracycline antibiotic arugomycin intercalates between the basepairs of the hexamer duplex d(5'-GCATGC)2 at the 5'-CpA and 5'-TpG binding sites. In the complex two drug molecules are bound per duplex with full retention of the dyad symmetry. Arugomycin adopts a threaded binding orientation with chains of sugars positioned in both the major and minor groove of the helix simultaneously. The complex is stabilized by hydrogen bonding, electrostatic and van der Waals interactions principally in the major groove and involving substituents on the rigidly oriented bicycloamino-glucose sugar of the antibiotic. A specific hydrogen bond is identified between the C2'-hydroxyl and the guanine N7 at the intercalation site. Together, interactions in the major groove appear to account for the intercalation specificity of arugomycin that requires both a guanine and thymine at the intercalation site. We are unable to identify any sequence specific interactions between the minor groove and the arugarose sugar (S1) which binds only weakly, through van der Walls contacts, over the d(GCA).d(TGC) trinucleotide sequence. The data indicate that the sugar chains of arugomycin are flexible and play little part in the interaction of the antibiotic with DNA. The intensity of sequential internucleotide NOEs identifies the intercalation site as being assymmetric. A family of conformers computed using restrained energy minimisation and molecular dynamics indicate that basepair buckling is a feature of the anthracycline intercalation site that may serve to maximise intermolecular van der Waals interactions by wrapping the basepairs around the antibiotic chromophore.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1647521      PMCID: PMC328249          DOI: 10.1093/nar/19.11.2897

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  20 in total

1.  1H nuclear magnetic resonance assignments for d-(GCATTAATGC)2 using experimental refinements of established procedures.

Authors:  W J Chazin; K Wüthrich; S Hyberts; M Rance; W A Denny; W Leupin
Journal:  J Mol Biol       Date:  1986-08-05       Impact factor: 5.469

2.  Comparative biological activity of nogalamycin and its analogs.

Authors:  B K Bhuyan; F Reusser
Journal:  Cancer Res       Date:  1970-04       Impact factor: 12.701

3.  Effects of DNA intercalating agents on topoisomerase II induced DNA strand cleavage in isolated mammalian cell nuclei.

Authors:  Y Pommier; R E Schwartz; L A Zwelling; K W Kohn
Journal:  Biochemistry       Date:  1985-11-05       Impact factor: 3.162

4.  Solution structure of the nogalamycin-DNA complex.

Authors:  X L Zhang; D J Patel
Journal:  Biochemistry       Date:  1990-10-09       Impact factor: 3.162

5.  Arugomycin, a new anthracycline antibiotic. III. Biological activities of arugomycin and its analogues obtained by chemical degradation and modification.

Authors:  A Shimosaka; H Kawai; Y Hayakawa; N Komeshima; M Nakagawa; H Seto; N Otake
Journal:  J Antibiot (Tokyo)       Date:  1987-09       Impact factor: 2.649

6.  Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II.

Authors:  K M Tewey; T C Rowe; L Yang; B D Halligan; L F Liu
Journal:  Science       Date:  1984-10-26       Impact factor: 47.728

7.  NMR studies of the interaction of the antibiotic nogalamycin with the hexadeoxyribonucleotide duplex d(5'-GCATGC)2.

Authors:  M S Searle; J G Hall; W A Denny; L P Wakelin
Journal:  Biochemistry       Date:  1988-06-14       Impact factor: 3.162

8.  Antitumor drug nogalamycin binds DNA in both grooves simultaneously: molecular structure of nogalamycin-DNA complex.

Authors:  Y C Liaw; Y G Gao; H Robinson; G A van der Marel; J H van Boom; A H Wang
Journal:  Biochemistry       Date:  1989-12-26       Impact factor: 3.162

9.  Footprinting studies on the interactions of nogalamycin, arugomycin, decilorubicin and viriplanin with DNA.

Authors:  K R Fox
Journal:  Anticancer Drug Des       Date:  1988-12

10.  Evidence of different binding sites for nogalamycin in DNA revealed by association kinetics.

Authors:  K R Fox; M J Waring
Journal:  Biochim Biophys Acta       Date:  1984-11-28
View more
  1 in total

1.  Reagent-Controlled α-Selective Dehydrative Glycosylation of 2,6-Dideoxy Sugars: Construction of the Arugomycin Tetrasaccharide.

Authors:  Joseph R Romeo; Luca McDermott; Clay S Bennett
Journal:  Org Lett       Date:  2020-04-13       Impact factor: 6.005

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.